Switch theme
Sign up to access all valuation multiples
Ryman Healthcare Ltd develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.
1984
n/a
LTM Revenue $455M
LTM EBITDA $137M
$2.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ryman Healthcare has a last 12-month revenue (LTM) of $455M and a last 12-month EBITDA of $137M.
In the most recent fiscal year, Ryman Healthcare achieved revenue of $388M and an EBITDA of -$30.2M.
Ryman Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ryman Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $455M | XXX | $388M | XXX | XXX | XXX |
| Gross Profit | $455M | XXX | $388M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 100% | XXX | XXX | XXX |
| EBITDA | $137M | XXX | -$30.2M | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | -8% | XXX | XXX | XXX |
| EBIT | $118M | XXX | -$41.5M | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | -11% | XXX | XXX | XXX |
| Net Profit | -$69.9M | XXX | $2.8M | XXX | XXX | XXX |
| Net Margin | -15% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ryman Healthcare's stock price is NZD 2 (or $1).
Ryman Healthcare has current market cap of NZD 2.1B (or $1.3B), and EV of NZD 4.7B (or $2.8B).
See Ryman Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.8B | $1.3B | XXX | XXX | XXX | XXX | $0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ryman Healthcare has market cap of $1.3B and EV of $2.8B.
Ryman Healthcare's trades at 7.5x EV/Revenue multiple, and 61.7x EV/EBITDA.
Equity research analysts estimate Ryman Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ryman Healthcare has a P/E ratio of -18.2x.
See valuation multiples for Ryman Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $2.8B | XXX | $2.8B | XXX | XXX | XXX |
| EV/Revenue | 6.2x | XXX | 7.5x | XXX | XXX | XXX |
| EV/EBITDA | 20.5x | XXX | 61.7x | XXX | XXX | XXX |
| EV/EBIT | 23.7x | XXX | -82.5x | XXX | XXX | XXX |
| EV/Gross Profit | 6.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | -18.2x | XXX | 31.3x | XXX | XXX | XXX |
| EV/FCF | -60.0x | XXX | 10.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialRyman Healthcare's last 12 month revenue growth is 29%
Ryman Healthcare's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Ryman Healthcare's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ryman Healthcare's rule of X is 104% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ryman Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 29% | XXX | 34% | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | -18% | XXX | 70% | XXX | XXX | XXX |
| Rule of 40 | 42% | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 104% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 111% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ryman Healthcare acquired XXX companies to date.
Last acquisition by Ryman Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Ryman Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ryman Healthcare founded? | Ryman Healthcare was founded in 1984. |
| Where is Ryman Healthcare headquartered? | Ryman Healthcare is headquartered in New Zealand. |
| Is Ryman Healthcare publicy listed? | Yes, Ryman Healthcare is a public company listed on NZE. |
| What is the stock symbol of Ryman Healthcare? | Ryman Healthcare trades under RYM ticker. |
| When did Ryman Healthcare go public? | Ryman Healthcare went public in 1999. |
| Who are competitors of Ryman Healthcare? | Similar companies to Ryman Healthcare include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Ryman Healthcare? | Ryman Healthcare's current market cap is $1.3B |
| What is the current revenue of Ryman Healthcare? | Ryman Healthcare's last 12 months revenue is $455M. |
| What is the current revenue growth of Ryman Healthcare? | Ryman Healthcare revenue growth (NTM/LTM) is 29%. |
| What is the current EV/Revenue multiple of Ryman Healthcare? | Current revenue multiple of Ryman Healthcare is 6.2x. |
| Is Ryman Healthcare profitable? | Yes, Ryman Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ryman Healthcare? | Ryman Healthcare's last 12 months EBITDA is $137M. |
| What is Ryman Healthcare's EBITDA margin? | Ryman Healthcare's last 12 months EBITDA margin is 30%. |
| What is the current EV/EBITDA multiple of Ryman Healthcare? | Current EBITDA multiple of Ryman Healthcare is 20.5x. |
| What is the current FCF of Ryman Healthcare? | Ryman Healthcare's last 12 months FCF is -$46.8M. |
| What is Ryman Healthcare's FCF margin? | Ryman Healthcare's last 12 months FCF margin is -10%. |
| What is the current EV/FCF multiple of Ryman Healthcare? | Current FCF multiple of Ryman Healthcare is -60.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
